The risk for adverse cardiac events in subjects between 3 and 20 years of age treated with methylphenidate or amphetamine salts for ADHD was determined in a retrospective study at University of Florida, Gainesville, FL
Executive Summary: Regulatory decisions and scientific statements regarding the management of Attent...
Objective . To evaluate the relationship between attention-deficit hyperactivity disorder (ADHD) and...
Young people with attention deficit hyperactivity disorder (ADHD) are now being treated with psychos...
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder that is often t...
BACKGROUND: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
Objective To identify the cardiovascular effects of long-acting methylphenidate administered for twe...
Background: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorde...
Researchers from Vanderbilt University, TN; Kaiser Permanente, California; and other centers conduct...
The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Amo...
Background: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD i...
The short-term cardiovascular effects of methylphenidate (MPH) and Adderall (ADL) were examined in a...
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder exhibited by d...
Attention-deficit hyperactivity disorder (ADHD) is associated with higher risk for fracture. Whether...
Executive Summary: Regulatory decisions and scientific statements regarding the management of Attent...
Objective . To evaluate the relationship between attention-deficit hyperactivity disorder (ADHD) and...
Young people with attention deficit hyperactivity disorder (ADHD) are now being treated with psychos...
Attention-deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder that is often t...
BACKGROUND: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
ABSTRACT The purpose of this article is to examine the association of adverse cardiovascular risks w...
Objective To identify the cardiovascular effects of long-acting methylphenidate administered for twe...
Background: Many children and adolescents with attention deficit/hyperactivity disorder (ADHD) are t...
Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorde...
Researchers from Vanderbilt University, TN; Kaiser Permanente, California; and other centers conduct...
The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Amo...
Background: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD i...
The short-term cardiovascular effects of methylphenidate (MPH) and Adderall (ADL) were examined in a...
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder exhibited by d...
Attention-deficit hyperactivity disorder (ADHD) is associated with higher risk for fracture. Whether...
Executive Summary: Regulatory decisions and scientific statements regarding the management of Attent...
Objective . To evaluate the relationship between attention-deficit hyperactivity disorder (ADHD) and...
Young people with attention deficit hyperactivity disorder (ADHD) are now being treated with psychos...
DOI
Add to ORKG